UBS Maintains Neutral on Lineage, Lowers Price Target to $36
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $36.
LINE is up 1.10% today. Volume is 866.0K vs a 30-day average of 1.05M (0.82x).
Lineage, Inc. is scheduled to report earnings Mon, Nov 9, 2026. Analysts expect EPS of $-0.13 on revenue of about $1.39B. Stocks often move sharply on earnings day.
UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:LINE) with a Neutral and lowers the price target from $45 to $36.
JP Morgan analyst Michael Mueller maintains Lineage (NASDAQ:LINE) with a Underweight and lowers the price target from $40 to $37.